location: Current position: Home-Yong Liu >> Scientific Research >> Paper Publications

Pterostilbene supplements carry the risk of drug interaction via inhibition of UDP-glucuronosyltransferases (UGT) 1A9 enzymes

Hits:

Indexed by:Journal Papers

Date of Publication:2019-12-05

Journal:Toxicology Letters

Included Journals:PubMed

Volume:320

Page Number:46-51

Key Words:Enzyme inhibition,Food-drug interactions,Pterostilbene,UDP- Glucuronosyltransferases

Abstract:Pterostilbene (PT) is a natural stilbene common in small berries and food supplements, possessing numerous pharmacological activities. However, whether PT can affect the activities of UDP-glucuronosyltransferases (UGT) enzymes remains unclear. The aim of the present study was to investigate the effect of PT on UGT activities and to quantitatively evaluate the food-drug interaction potential due to UGT inhibition. Our data indicated that PT exhibited potent inhibition against HLM, UGT1A6, UGT1A9, UGT2B7, and UGT2B15, moderate inhibition against UGT1A1, UGT1A3, UGT1A8, and UGT2B4, negligible inhibition against UGT1A4, UGT1A7, UGT1A10, and UGT2B17. Further kinetic investigation demonstrated that PT exerted potent noncompetitive inhibition 4-MU glucuronidation by UGT1A9, with IC50 and Ki values of 0.92 μM and 0.52 ± 0.04 μM, respectively. Quantitative prediction study suggested that coadministration of PT supplements at 100 mg/day or higher doses may result in at least a 50% increase in the AUC of drugs predominantly cleared by UGT1A9. Thus, the coadministration of PT supplements and drugs primarily cleared by UGT1A9 may result in potential drug interaction, and precautions should be taken when coadministration of PT supplements and drugs metabolized by UGT1A9.Copyright © 2019 Elsevier B.V. All rights reserved.

Pre One:The pharmacokinetic interaction between irinotecan and sunitinib

Next One:The pharmacokinetic interaction between irinotecan and sunitinib